INCB# [002]

Related by string. INCB# [001] . INCB# [003] * * advanced compound INCB# . topical INCB# . compound INCB# . inhibitor INCB# *

Related by context. All words. (Click for frequent words.) 72 ruxolitinib 71 Traficet EN 70 ganetespib 70 tanespimycin 70 HuMax CD4 70 BAY #-# 69 PXD# 69 AP# [003] 69 JAK inhibitor 69 PS# [001] 69 Amrubicin 69 Phase 2a trial 69 phase IIb clinical 68 INCB# [001] 68 eltrombopag 68 DDP# 68 Phase Ib study 68 INC# 68 PRTX 68 forodesine 68 IMGN# 68 ISIS # 67 Ambrisentan 67 RG# [001] 67 OncoVEX GM CSF 67 Phenoptin 67 NVA# 67 tivozanib 67 Archexin 67 EOquin 67 HCV protease inhibitor 67 XL# [003] 67 eniluracil 67 Golimumab 67 alvimopan 67 Mipomersen 67 PRT# 67 MGCD# [001] 66 CYT# 66 phase IIa clinical 66 albinterferon alfa 2b 66 INCB# [003] 66 Tamibarotene 66 Xanafide 66 XmAb# 66 vidofludimus 66 Dapagliflozin 66 ponatinib 66 tezampanel 66 cannabinor 66 ATL# [001] 66 PROMACTA 66 Chemophase 66 blinatumomab 66 Zerenex 66 elotuzumab 66 FOLOTYN 66 Virulizin ® 66 NGX# 66 Corlux 66 Neurodex 66 Perifosine 66 CCX# 66 EOquin TM 66 MAGE A3 ASCI 66 alvespimycin 66 Phase 2b trial 66 Sym# 66 PEG SN# 66 HGS ETR1 65 RDEA# 65 phase IIb 65 thymalfasin 65 GALNS 65 AZILECT R 65 metaglidasen 65 SAR# [004] 65 Carfilzomib 65 pomalidomide 65 virus HCV protease inhibitor 65 HuMax CD# 65 perifosine 65 aclidinium 65 Laquinimod 65 ularitide 65 Azedra TM 65 Phase 2b 65 belinostat 65 myelofibrosis MF 65 Triolex 65 obatoclax 65 huC# DM4 65 compound INCB# 65 CR# vcMMAE 65 posaconazole 65 Panzem R NCD 65 Androxal TM 65 Telaprevir 65 LY# [003] 65 teduglutide 65 teriflunomide 65 axitinib 65 TG# [003] 65 methylnaltrexone 65 Raptiva ® 65 Amigal 65 YONDELIS 65 Serdaxin 65 Phase 1b trial 65 octreotide implant 65 proteasome inhibitor 65 TREANDA 65 selective androgen receptor modulator 65 rNAPc2 65 myelofibrosis 65 OvaRex ® MAb 65 Zelrix 65 sodium glucose cotransporter 65 BRIM2 64 Azedra 64 valopicitabine 64 pharmacokinetic PK study 64 lomitapide 64 PDE4 inhibitor 64 Debio 64 pralatrexate 64 Phase IIa trial 64 Aurexis 64 Gabapentin GR 64 TRIOLEX 64 ARIKACE 64 Genasense ® 64 Guanilib 64 Proxinium TM 64 Darusentan 64 dose cohort 64 Locteron 64 Phase IIIb clinical 64 PEG PAL 64 Panzem R 64 IRX 2 64 phase IIb trial 64 AzaSite Plus 64 Plicera 64 oral prodrug 64 cell lymphoma CTCL 64 Dacogen injection 64 CD# antibody [001] 64 diabetic neuropathic pain 64 Safinamide 64 registrational 64 Phase 2a 64 Bortezomib 64 mertansine 64 ozarelix 64 torezolid phosphate 64 Phase Ib 64 anticancer compound 64 riociguat 64 tesetaxel 64 AQ4N 64 AEGR 64 enzastaurin 64 bardoxolone 64 linaclotide 64 Capesaris 64 Firazyr 64 atacicept 64 GAMMAGARD 64 HuMax EGFr 64 Dalbavancin 64 vascular disrupting agent 64 voreloxin 64 JAK1 64 pradefovir 64 oral ridaforolimus 64 favorable tolerability 64 ATryn R 64 apremilast 64 RAPAFLO 64 Phase IIa clinical 64 DAVANAT 64 Reverset 64 Treanda 64 Ophena TM 64 Phase 2b study 63 NUVIGIL 63 Alocrest 63 telbivudine 63 CYC# 63 brivaracetam 63 TACI Ig 63 rFIXFc 63 GSK# [001] 63 tipifarnib 63 MAP# 63 dirucotide 63 BAL# [002] 63 Annamycin 63 sapacitabine 63 Phase 1b 63 dose cohorts 63 CINOD 63 SNT MC# 63 Pimavanserin 63 budesonide foam 63 orally administered inhibitor 63 PREOS 63 EVIZON 63 TRO# 63 pegylated interferons 63 bazedoxifene 63 RAPTIVA 63 CIMZIA TM 63 Ventavis 63 TBC# 63 FTY# 63 AEG# 63 administered subcutaneously 63 tafamidis 63 Ceflatonin 63 Atiprimod 63 relapsed multiple myeloma 63 phase 2a 63 Octreolin 63 favorable pharmacokinetic profile 63 Marqibo 63 MoxDuo IR 63 vandetanib 63 Phase #b/#a trial 63 confirmatory Phase III 63 velafermin 63 Icatibant 63 galiximab 63 Phase 2b clinical 63 urocortin 2 63 XL# XL# XL# 63 subcutaneous formulation 63 Targretin 63 ZYBRESTAT 63 lupus nephritis 63 UPLYSO 63 Pirfenidone 63 Phase #/#a 63 R#/MEM # 63 CoFactor 63 indacaterol 63 bendamustine 63 Phase IIb 63 mapatumumab 63 ulimorelin 63 Oracea 63 Linaclotide 63 Pemetrexed 63 amrubicin 63 RGB # 63 Civacir 63 CTAP# Capsules 63 lorvotuzumab mertansine 63 histone deacetylase HDAC inhibitor 63 lumiliximab 63 maribavir 63 Phase IIb trial 63 REYATAZ R 63 relapsed refractory multiple myeloma 63 Cetrorelix 63 CBLC# 63 LibiGel ® 63 Rotigotine 63 receptor tyrosine kinase inhibitor 63 Seliciclib 63 Pazopanib 63 Taxotere ® 63 DAVANAT R 63 Ofatumumab 63 ALGRX 63 Naproxcinod 63 dasatinib Sprycel ® 63 Phase 2a clinical 63 Irinotecan 63 injectable formulation 63 Personalized Immunotherapy 62 mipomersen 62 HQK 62 otelixizumab 62 Allovectin 7 ® 62 docetaxel Taxotere ® 62 L BLP# 62 Tezampanel 62 QVA# 62 BCX# 62 CDK inhibitor 62 LAF# 62 MDV# 62 tolerability profile 62 tamibarotene 62 MIRCERA 62 prucalopride 62 PSN# [002] 62 LEP ETU 62 INT# [002] 62 ProSavin 62 ZOLINZA 62 Tyrima 62 Restanza 62 IPX# 62 Telatinib 62 trabectedin 62 pertuzumab 62 CYCLOSET 62 ENMD # 62 Targretin capsules 62 SinuNase 62 romiplostim 62 SPRYCEL ® 62 Sprycel dasatinib 62 tiapamil 62 APOPTONE 62 Kamada AAT 62 ongoing Phase 1b 62 tolerability profiles 62 BEMA TM Fentanyl 62 Natalizumab 62 photoprotective drug 62 Plenaxis TM 62 ORENCIA ® 62 Zolinza 62 glatiramer acetate 62 talactoferrin 62 registrational trial 62 subcutaneously administered 62 somatostatin analogue 62 edoxaban 62 Bicifadine 62 anticancer agent 62 Aflibercept 62 metastatic HRPC 62 tasimelteon 62 octreotide acetate 62 palifosfamide 62 MEK inhibitors 62 TELCYTA 62 LymphoStat B 62 VAPRISOL 62 APTIVUS r 62 CRMD# 62 pseudobulbar affect PBA 62 TYZEKA 62 refractory gout 62 castration resistant prostate cancer 62 pharmacodynamic 62 regorafenib 62 ocrelizumab 62 Phase IIb trials 62 Iloperidone 62 APTIVUS 62 pan HDAC inhibitor 62 Octreotide 62 fosbretabulin 62 sorafenib Nexavar 62 rotigotine 62 AVN# [001] 62 IL# PE#QQR 62 Huntexil 62 delafloxacin 62 elagolix 62 decitabine 62 EGS# 62 imatinib Gleevec ® 62 CANCIDAS 62 QAB# 62 Azixa 62 Forodesine HCl 62 tolerability 62 COMFORT II 62 Dasatinib 62 CEQ# 62 CAELYX 62 Increlex ® 62 Factor VIIa 62 Eltrombopag 62 Aplidin 62 Phase IIB 62 novel VDA molecule 62 leading oral taxane 62 ALVESCO HFA 62 Ozarelix 62 Leukine 62 humanized anti 62 GW# [003] 62 Troxatyl 62 Nexavar sorafenib 62 canakinumab 62 BEMA Buprenorphine 62 herpetic keratitis 62 baminercept 62 Rebif ® 62 Ostarine 62 Pivotal Phase III 62 romidepsin 62 satraplatin 62 Bezielle 62 ALN PCS 62 AZILECT ® 62 BENLYSTA 62 S/GSK# 62 ambrisentan 62 ICA # 62 mGluR5 negative 62 mRCC 62 VA# [002] 62 carfilzomib 62 CIMZIA ™ 62 6R BH4 62 ataluren 62 ATL/TV# 62 peginesatide 62 FOLOTYN ® 62 FavId 62 OncoVEX 62 dalbavancin 62 PF # [001] 62 tipranavir 62 angiogenesis inhibitor 62 RSD# 62 nitazoxanide 62 rilonacept 61 huN# DM1 61 PRX # 61 elacytarabine 61 crizotinib PF # 61 picoplatin 61 pivotal Phase III 61 Phase 2b clinical trials 61 Saxagliptin 61 Phase IIa 61 Tasimelteon 61 tasocitinib 61 Clolar ® 61 PNP inhibitor 61 silodosin 61 Asentar 61 Vilazodone 61 Blinatumomab 61 dacetuzumab 61 Tesetaxel 61 bifeprunox 61 DR Cysteamine 61 ORENCIA R 61 GRN#L 61 cediranib 61 Zybrestat 61 FTY# fingolimod 61 RLY# 61 OPAXIO 61 veltuzumab 61 lubiprostone 61 dimebon 61 PEG Interferon lambda 61 orBec 61 Symadex 61 Alpharadin 61 tigecycline 61 Erlotinib 61 inhibitor RG# 61 monotherapy 61 ADVEXIN 61 Elagolix 61 HspE7 61 BrachySil TM 61 SCH # 61 efalizumab 61 Phase IIb clinical 61 selective modulator 61 EFAPROXYN 61 IPL# 61 ALN TTR 61 placebo controlled clinical 61 OMNARIS Nasal Spray 61 sunitinib malate 61 radezolid 61 Cleviprex TM clevidipine 61 ACZ# 61 Alvesco R 61 RhuDex ® 61 Zenvia Phase III 61 ELACYT 61 Entereg R 61 oral rivaroxaban 61 INTEGRILIN 61 Catena ® 61 LY# [002] 61 anti leukemic 61 MEK inhibitor 61 DPP4 61 Phase III pivotal 61 glufosfamide 61 Voreloxin 61 panitumumab 61 metastatic renal cell carcinoma 61 darapladib 61 Synavive 61 hematological cancers 61 liposomal formulation 61 DXL# 61 severe hypercholesterolemia 61 Albuferon 61 metastatic hormone refractory 61 SARMs 61 NEBIDO 61 Tanespimycin 61 BNC# 61 investigational humanized monoclonal antibody 61 Pafuramidine 61 ADX# 61 BMS # 61 ACTEMRA TM 61 Denufosol 61 IMA# 61 ixabepilone 61 beta 1a 61 BRIM3 61 ILLUMINATE 61 JAK inhibitors 61 liposomal amphotericin B 61 CA4P 61 Interferon alpha 61 MNTX 61 drug ISA# 61 Zalbin 61 active comparator 61 KRN# 61 investigational pan BCR 61 visilizumab 61 Aryplase 61 dose escalation trial 61 Increlex R 61 Technosphere Insulin 61 radiation sensitizer 61 Evoltra ® 61 relapsed MM 61 Nebido 61 Neulasta ® 61 PEG IFN 61 elvucitabine 61 MOZOBIL 61 Nuvion 61 APD# 61 betrixaban 61 QNEXA 61 tolvaptan 61 evaluating tivozanib 61 Evoltra 61 zileuton 61 pitavastatin 61 ustekinumab 61 SLx 61 lixisenatide 61 initiate Phase 1b 61 IDX# 61 LCP Tacro 61 laquinimod 61 MYCAMINE 61 ciclesonide 61 NP2 Enkephalin 61 amifampridine phosphate 61 Telbivudine 61 Phase IIIb 61 daclizumab 61 HGS ETR2 61 ritonavir boosted 61 confirmatory Phase 3 61 OXi# 61 multicenter Phase 61 FASLODEX 61 Phase #/#a trial 61 DB# [003] 61 dextromethorphan quinidine 61 ISENTRESS 61 Perforomist TM Inhalation Solution 61 Aptivus ® 61 Gleevec imatinib mesylate 61 vemurafenib 61 Kuvan 61 Genz # 61 BIBW 61 zalutumumab 61 Daclizumab 61 CCR5 antagonist 61 Degarelix 61 dyskinesia PD LID 61 LEUKINE 61 ALD# 61 Viprinex 61 Urocidin 61 Milnacipran 61 SUTENT ® 61 investigational compound 61 phase IIa 61 BYDUREON 61 Tasigna nilotinib 61 iniparib 61 pharmacokinetics PK 61 Amplimexon 61 MAA submission 61 JANUVIA 61 celgosivir 61 aclidinium bromide 61 denufosol 61 Nanobody 61 Vicriviroc 61 AeroLEF TM 61 custirsen 61 Exelixis XL# 61 Indaflex TM 61 leukemia AML 61 ALN TTR# 61 corticosteroid dexamethasone 61 maraviroc 61 Stedivaze 61 vorinostat 61 Ocrelizumab 61 BLA filing 61 polymerase inhibitor 61 reslizumab 61 terlipressin 61 Elocalcitol 61 Hyphanox 61 AMR# 61 sodium thiosulfate STS 61 TELINTRA 61 HCD# [002] 61 DEB# 61 Panzem 61 darunavir 61 ofatumumab 61 Alzhemed TM 61 trastuzumab DM1 T DM1 61 ZADAXIN 61 Nexavar ® 61 ACAPODENE 61 Rivaroxaban 61 erlotinib Tarceva ® 61 gastrointestinal stromal tumors GIST 61 PROVIGIL 60 Vicinium TM 60 aflibercept VEGF Trap 60 Azilect ® 60 Cloretazine R VNP#M 60 Phase III Clinical Trial 60 Metastatic Melanoma 60 Allovectin 7 60 Rezular 60 generation Hsp# inhibitor 60 Abiraterone acetate 60 IMC A# 60 HER2 positive metastatic breast 60 Zoraxel 60 Frova ® 60 cariprazine 60 USL# 60 Stelara 60 Vandetanib 60 Bronchitol 60 EDEMA3 60 Allovectin 7 R 60 BROVANA 60 SCCHN 60 small molecule Hedgehog 60 LIALDA 60 Desmoteplase 60 THALOMID 60 Nuedexta 60 Glufosfamide 60 QLT# 60 ribavirin RBV 60 depsipeptide 60 prGCD 60 Perforomist ™ Inhalation Solution 60 Tarceva erlotinib 60 vilazodone 60 adipiplon 60 tocilizumab 60 Avanafil 60 torezolid 60 ALN VSP 60 Hycamtin 60 Darunavir 60 Advexin 60 INTEGRILIN ® 60 bicifadine 60 sipuleucel T 60 hematologic malignancies 60 refractory multiple myeloma 60 eprotirome 60 milatuzumab 60 noninfectious uveitis 60 FOLPI 60 omacetaxine 60 TMC# [002] 60 Pralatrexate 60 CLARITY study 60 Soriatane 60 CINTREDEKIN BESUDOTOX 60 Phase IIb clinical trials 60 ALKS 60 CORT # 60 viral kinetics 60 PHX# 60 SILENOR TM 60 Sudhir Agrawal D.Phil 60 Zenvia TM 60 PANVAC VF 60 relapsed ovarian cancer 60 gefitinib Iressa 60 trospium 60 Cethrin 60 antithrombotic 60 biologic therapy 60 omecamtiv mecarbil 60 JAK2 inhibitor 60 TroVax 60 Campath 60 Aclidinium 60 incyclinide 60 generation purine nucleoside 60 Lubiprostone 60 volociximab 60 lurasidone 60 BrachySil 60 Darinaparsin 60 Apoptone 60 CCX# B 60 DACH platinum 60 clofarabine 60 Fludara 60 seliciclib 60 rALLy trial 60 sunitinib 60 alefacept 60 Fodosine 60 Ticagrelor 60 pexiganan 60 entinostat 60 paliperidone palmitate 60 MYDICAR ® 60 Aptivus 60 MBP# [001] 60 rindopepimut 60 PLX# 60 Peginterferon 60 PRISTIQ 60 VEGF inhibitor 60 Campath ® 60 Torisel 60 cutaneous T cell 60 ruboxistaurin 60 ara C 60 Phase Ib clinical 60 zileuton CR 60 randomized controlled Phase 60 octreotide 60 catheter occlusion 60 CRx 60 Proquin XR 60 Loramyc R 60 sorafenib tablets 60 abatacept Orencia 60 Omacetaxine mepesuccinate 60 Talabostat 60 dose escalation Phase 60 renin inhibitor 60 PREOS R 60 Sanctura XR 60 dacarbazine 60 dexpramipexole 60 Epratuzumab 60 Cimzia ® certolizumab pegol 60 Cellegesic 60 TEMODAL 60 BiTE antibody 60 #ME# 60 2 methoxyestradiol 60 luliconazole 60 samalizumab 60 Vaprisol 60 XL# XL# 60 Fulvestrant 60 mitomycin 60 CCR9 antagonist 60 PSMA ADC 60 Clavis Pharma 60 TPI ASM8 60 fluticasone furoate 60 investigational hepatitis C 60 dosing regimens 60 long acting muscarinic 60 cetuximab Erbitux ® 60 XL# XL# XL# XL# 60 Xibrom 60 PROCHYMAL 60 ceftaroline 60 Crofelemer 60 humanized monoclonal antibody 60 darinaparsin 60 Microplasmin 60 docetaxel Taxotere R 60 JAK2 inhibitors 60 Exelixis compounds 60 Phase Ib II 60 EGFR inhibitors 60 Exherin TM 60 Phase 2b Clinical Trial 60 Onco TCS 60 dasatinib Sprycel 60 mGluR5 NAM 60 AAG geldanamycin analog 60 SRT# [003] 60 including eniluracil ADH 60 neratinib 60 zanolimumab 60 Tavocept 60 Androxal 60 AZD# 60 pharmacokinetic profile 60 Northera 60 carcinoid syndrome 60 ATryn ® 60 abiraterone acetate 60 PDX pralatrexate 60 Enzastaurin 60 Aurora kinase 60 Betaferon R 60 rALLy 60 Randomized Phase 60 sitaxsentan 60 TYKERB 60 elvitegravir 60 Adlea 60 VPRIV 60 BRAF inhibitor 60 TriRima 60 Phase III clinical 60 thalidomide Thalomid 60 SUCCEED trial 60 Cinryze ™ 60 micafungin 60 generation antisense inhibitor 60 nilotinib 60 PROSTVAC TM 60 ASCO abstract 60 investigational antiplatelet agent 60 Tarceva TM 60 ARRY 60 CRLX# 60 interferon beta 1b 60 Emselex 60 Celgene Revlimid 60 TREDAPTIVE 60 vosaroxin 60 preclinically 60 PrevOnco 60 LHRH antagonist 60 Epanova 60 Diamyd ® 60 solithromycin 60 Omacetaxine 60 muraglitazar 60 cilengitide 60 treprostinil 60 apaziquone 60 Vidaza azacitidine 60 Phase IIb Trial 60 pegylated interferon alfa 60 albiglutide 60 phase Ib 60 bosutinib 60 Belimumab 60 xanthine oxidase inhibitor 60 ANCHOR trial 60 Oracea TM 60 nucleoside analogs 60 dose escalation clinical 60 pegfilgrastim 60 lymphoma CTCL 60 Adalimumab 60 Silodosin 60 Phase IIa trials 60 Reolysin 60 OMS#HP 60 Solasia 60 Amitiza 60 LEVADEX 60 vismodegib 60 KNS # 60 Akt inhibitor 60 LymphoStat B TM 60 Anticalin R 60 Hsp# inhibitor 60 acute HAE attacks 60 EDEMA4 60 Zingo TM 60 ARCOXIA 60 GSK# [002] 60 telcagepant 60 nucleoside analog 60 IPLEX 60 Anturol TM 60 T DM1 60 Durezol 60 AMEVIVE 60 NOXAFIL 60 ASA# 60 Phase III 60 fidaxomicin 60 Serdaxin ® 60 #I TM# 60 oxymorphone ER 60 EndoTAG 60 metastatic CRC 60 asenapine 60 PROVENGE sipuleucel T 59 Pramipexole 59 Relivar 59 iclaprim 59 Zorbtive TM 59 phase IIb study 59 oral antiviral 59 Vernakalant 59 NU# [001] 59 LymphoStat B belimumab 59 PCK# 59 Clevudine 59 Alfimeprase 59 panitumumab Vectibix 59 ONTAK 59 Benlysta belimumab 59 prodrug stimulant 59 trabedersen 59 MAXY G# 59 MGCD# [002] 59 placebo controlled Phase 59 orally bioavailable 59 trastuzumab DM1 59 nucleoside analogue 59 SPP# [001] 59 platelet inhibitor 59 plasma kallikrein inhibitor 59 Focalin XR 59 IIa trial 59 INTELENCE 59 alemtuzumab 59 Diovan HCT 59 NEUMUNE 59 Inhalation Solution 59 Soliris TM eculizumab 59 granisetron 59 lesinurad 59 Prochymal 59 TKM ApoB 59 MoxDuo 59 Luteinizing Hormone Releasing Hormone 59 pharmacokinetic PK 59 HoFH 59 ACTEMRA 59 Phase III ALLEGRO 59 Rhucin 59 mCRC patients 59 Ridaforolimus 59 briakinumab 59 MGd 59 alkylating agent 59 Virulizin R 59 Cimzia 59 G#DT 59 rhIGF-I/rhIGFBP-3 59 AGGRASTAT R 59 TOLAMBA 59 nab paclitaxel 59 SEROQUEL 59 Onbrez Breezhaler 59 alpha 2a 59 polycythemia vera PV 59 dextofisopam 59 pharmacodynamic PD 59 lintuzumab 59 ibandronate 59 Radezolid 59 multi kinase inhibitor 59 MACUGEN 59 Iluvien ® 59 GLYX 59 chemotherapeutic agent 59 dasatinib 59 Doxil ® 59 CaPre TM 59 hematological malignancies 59 iloperidone 59 Phase #b/#a

Back to home page